Damion Valletta, DO
Orthopaedic Surgery · San Diego, CANPI 1205885951
Payments from drug & device makers
Across 123 payments — averaging $199.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conformis, Inc.$17K
- Smith+Nephew$3K
- Arthrex$2K
- Stryker$2K
- Elevate Surgical Co$1K
- Zyla Life Sciences, Inc.$244
- plus $650 from 10 others
What the payments were for
- Speaking & faculty fees$12,25050%
- Travel & lodging$8,11433%
- Food & beverage$4,17117%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conformis, Inc. | 22 | $16,517 |
| Smith+Nephew | 10 | $2,620 |
| Arthrex | 24 | $1,716 |
| Stryker | 17 | $1,514 |
| Elevate Surgical Co | 5 | $1,273 |
| Zyla Life Sciences, Inc. | 25 | $244 |
| Linvatec Corporation | 7 | $231 |
| Orthalign Inc | 1 | $150 |
| Johnson & Johnson(2 entities) | 4 | $92 |
| DJO, LLC | 1 | $37 |
| Assertio Therapeutics, Inc. | 2 | $37 |
| Bioventus LLC | 1 | $29 |
| Portola Pharmaceuticals, LLC | 1 | $24 |
| Zimmer Biomet | 1 | $20 |
| ERMI LLC | 1 | $16 |
| Convatec Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iTotal Identity PS$8,438
- Identity Imprint Knee Replacement System$8,075
- ACUFEX Meniscal Root Repair$2,141
- Healicoil$1,873
- CAP-FIX$1,736
- NOVOSTITCH$1,736
- Q-FIX$1,736
- MAKO$1,012
- iTotal Identity Cruciate Retaining Knee Replacement System$450
- Bone Anchors with Arthroscopic Delivery System$297
- ORTHALIGN PLUS$150
- LINVATEC HIP PRESERVATION SYSTEM$116
How this compares
$24,535 in reported general payments places this provider in the 80th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $266 |
| Meloxicam | 30 | $90 |
| Gabapentin | 16 | $60 |
| Diclofenac Sodium | 14 | $29 |
| Amoxicillin | 17 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Diego
- Peter NewtonSan Diego$7M
- Joseph JankiewiczSan Diego$2.6M
- Mark McBrideSan Diego$2.6M
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.